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Background: Pneumonia is among the foremost causes of hospitalization and mortality in patients residing in
extended care facilities. Despite its prevalence, there is currently little literature focusing on the course and
management of nursing home-acquired pneumonia (NHAP) in the emergency department (ED). Our objective was
to investigate the ED presentation, course, management and outcomes in patients admitted through the ED with
NHAP.
Methods: A retrospective chart review of nursing home patients with a presumptive or final diagnosis of
pneumonia admitted through the ED was performed at two large hospitals in Detroit, Michigan.
Results: A total of 296 patients were included in the study from 2002 to 2007 with a mean age of 81.1 years (SD ± 10.95)
and 55.4% females. Blood cultures were performed on 90.8% of patients in the ED; 17.8% of these revealed growths, but
half of these were considered contaminants. Initial chest x-ray in the ED was read as possible pneumonia in 18.2% of
patients; 73.9% were started on antibiotics (ABX) in the ED. Mean hospital length of stay (LOS) was 10.75 days (SD ± 9.35)
and in-hospital mortality was 16.2%. Time until first ABX in univariate analysis was nearly significant (p = 0.053) for mortality
prediction, and the appropriate versus inappropriate ABX (per the Infectious Diseases Society of America and American
Thoracic Society guidelines) did not affect mortality. Patients treated with a single ABX had significantly increased LOS
(p = 0.0089). There was poor correlation between LOS and time until first ABX as well as LOS and time until appropriate
ABX with a correlation coefficient of −0.048 (p = 0.42) and −0.08 (p = 0.43), respectively.
Conclusions: In this data set of NHAP patients admitted through the ED, we found a surprisingly low prevalence of
true-positive blood cultures, high incidence of antibiotic pre-treatment at nursing homes prior to admission, high hospital
mortality and low immunization rates. There was a wide spectrum of pathogens grown in blood culture. Only two thirds
of the patients had dyspnea at presentation, and less than half had either cough or fever. On physical examination, about
one fourth had no clinical findings consistent with pneumonia. Further, less than one fifth of chest x-rays were interpreted
as possible pneumonia.
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Pneumonia is among the foremost causes of hos-
pitalization and mortality in patients residing in
extended care facilities [1-8]. The microbes causing
nursing home-acquired pneumonia (NHAP) are not
well defined and include a wide spectrum from patho-
gens involved in community-acquired pneumonia (CAP)* Correspondence: sayaz@med.wayne.edu
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in any medium, provided the original work is pto those specific to nosocomial infections [9,10]. In 2005,
the Infectious Diseases Society of America (IDSA) and
American Thoracic Society (ATS), based upon data avail-
able to them, recommended empiric antibiotic treatment
(ABX) guidelines for healthcare-acquired pneumonia
(HCAP) including NHAP [11]. These treatment recom-
mendations have not yet realized universal adherence,
which may be due in part to the paucity of data available
on NHAP [12,13].
It has been well documented that the discrepancy in de-
fining NHAP is an impediment toward a standardizedOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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scoring system for hospitalized patients with NHAP has
also led to prognostic models that are inadequate in strati-
fying disease severity [12]. According to the 2005 ATS/
IDSA guidelines, a new or progressive infiltrate seen on
chest X-ray plus compatible clinical signs, such as new-
onset fever with temperature greater than 38°C, purulent
sputum, leukocytosis or hypoxia, are essential features for
the clinical diagnosis of HCAP, including NHAP [11].
Latest evidence suggests that transfer of nursing home
patients with pneumonia to acute care facilities resulted
in minor and insignificant improvement in mortality or
morbidity when compared with patients who were
treated at the nursing homes [14]. Once admitted, these
patients are frequently managed as CAP in the hospital
[1]. The management of NHAP continues to be contro-
versial because of the scarcity of information on risk fac-
tors and diagnosis specific to this group of patients and
lack of randomized controlled clinical trials that could
help determine the best antimicrobial treatment regi-
men, length of treatment and rapid molecular tech-
niques to ascertain etiological agents [15]. A previous
study investigated the attitudes of physicians toward
NHAP treatment guidelines and found that the core ob-
stacles to implementation of the ATS/IDSA guidelines
are apprehensions regarding the practicality of using the
suggested regimens and absence of documented im-
proved outcomes [13].
Advances in modern medicine have led to a rapid in-
crease in the aging population with a subsequent in-
crease in the number of elderly population requiring
medical care [16]. An increase in the annual incidence
of NHAP of up to 1.9 million cases is expected over the
next 3 decades [14]. Despite its prevalence, there is
currently little literature focusing on the course and
management of NHAP in the ED. Similarly, little is
known regarding the early predictors of mortality in
these patients in the ED. Our objective was to investi-
gate the ED presentation, course, management, out-
comes, pathogens, appropriateness of ABX, time to firstTable 1 Comorbidities and antibiotics started at the nursing









Liver disease 1.7ABX administration and efficacy of ABX in relation to
mortality and length of stay (LOS) as well as early pre-
dictors of mortality and LOS in patients admitted
through the ED with NHAP. An understanding of the
risk factors and outcomes of these patients is critical in
the design of prevention and treatment strategies.
Methods
An Institutional Review Board (IRB)-approved, retro-
spective chart review was performed at two large ter-
tiary care, academic teaching hospitals in Michigan.
Henry Ford Hospital in Detroit is an 800-bed urban
hospital with 93,000 emergency department visits an-
nually. Similarly, Beaumont Hospital in Royal Oak is a
1000-bed community hospital with 115,000 emergency
department visits per year.
Patients that resided in a nursing home or an ex-
tended care facility and who were admitted through the
ED with a presumptive or final diagnosis of pneumonia
were included in this retrospective chart review study.
Patients were excluded from data abstraction if any of
the following were noted during data abstraction: active
cancer, tuberculosis, HIV, any immune suppression and
hospitalization within the 3 weeks prior to the study
visit. A standardized chart abstraction was performed
collecting patient demographics, laboratory studies, ra-
diographs, comorbidities, LOS, course of treatment,
final outcome and ABX (pre- and post-ATS/IDSA
guidelines). Our review of ABX included the time that
the first antibiotics were ordered and administered and
time until appropriate antibiotic administration (per
the ATS/IDSA guidelines for HCAP). Additionally, we
captured recommended antimicrobial therapy versus
single antibiotic treatment on mortality and LOS. The
included cases were retrospectively reviewed by trained
abstractors using a standardized abstraction form. This
study was performed in accordance with the previously
published methods of Gilbert and colleagues [17].
All variables were entered into Statistical Package for
Social Sciences (SPSS version 17.0© SPSS Inc.) andhome
Nursing home antibiotics % of Patients
Fluoroquinolones 14.5
































Figure 1 Pathogens revealed in blood culture performed in the ED.
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ard deviations were calculated for continuous variables
and frequencies determined for categorical variables.
Categorical variables were examined using Pearson’s chi-
square and Fisher’s exact test where appropriate. Continu-
ous variables were analyzed using a Wilcoxon rank test and

























Figure 2 Antibiotic therapy started in the ED.regression analyses were performed to determine the stron-
gest predictors of mortality.
Results
A total of 296 patients were included in the study from
2002 to 2007. Out of these 206 (69.6%) patients were ad-
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Table 2 Predictors of mortality in the ED
Parameter estimate P value Odds ratio 95% Confidence interval
Heart rate 0.0117 0.028 1.012 1.001-1.022
Temperature −0.4184 0.0080 0.66 0.48-0.90
Mental status change 1.4054 0.0005 4.08 1.84-9.01
Hemoglobin −1.1004 0.0042 0.33 0.16-0.71
Hematocrit 0.2916 0.016 1.34 1.06-1.70
BUN 0.0124 0.037 1.012 1.001-1.024
Ayaz et al. International Journal of Emergency Medicine 2014, 7:19 Page 4 of 7
http://www.intjem.com/content/7/1/19were admitted to Henry Ford Hospital. The mean age of
patients was 81.1 years (SD ± 10.9). The gender distribu-
tion was 164 (55.4%) females and 132 (44.6%) males. A
total of 237 (80.1%) patients had pneumonia as one
of the admission diagnoses. Other admission diagnoses
were 20.9% sepsis, 17.2% UTI, 10.1% dehydration, 11.8%
CHF, 9.5% acute renal failure/renal insufficiency, 7.1%
acute respiratory failure, 6.8% COPD and 4.5% atrial fib-
rillation; 20.6% of the patients who had an admission
diagnosis of pneumonia did not have a discharge diagno-
sis of pneumonia; 18.9% had received vaccinations in the
past 1 year; 11.5% were vaccinated against influenza and
14.9% were vaccinated against pneumococcus. Eighty-
two (27.7%) patients had antibiotic therapy initiated in
the nursing home (Table 1).
Blood cultures were performed on 90.87% of patients
in the ED, 17.8% of whom revealed growth of organ-
isms; however, 50% of these were considered to be
contaminants. Contaminants were either defined as
such in the medical record or were coagulase-negative
staphylococcus in a non-immunocompromised patient
(Figure 1). Sputum culture was obtained in 28% of the
patients, 83.1% of which grew bacteria, none of which
correlated to the identified blood pathogens. Two hun-





















Figure 3 Symptoms on presentation to the ED.in the ED (Figure 2). Cardiac enzymes were drawn in
75.7% of ED patients and were positive in 13.85%. On
initial ED ECG, 25.7% had signs of ischemia and 18.2%
of the patients showed signs of pneumonia on their ini-
tial ED chest X-ray as interpreted by the final radiolo-
gist report.
Of the patients, 41.2% were admitted to the regular
medical floor, 19.3% to the telemetry floor, 20.9% to
step-down unit and 17.6% to the ICU; 12.16% of the pa-
tients were intubated for a mean duration of 9.28 days
(SD ± 12.2). Mean hospital LOS was 10.75 days (SD ±
9.35), mean LOS in the ICU was 1.72 days (SD ± 5.1),
mean LOS in step-down/progressive care was 2.57 days
(SD ± 5.3), and mean LOS on regular medical floor with
telemetry services was 6.2 days (SD ± 7.3). Of the
patients, 65.5% were discharged back to the nursing
home, 3% were discharged to a rehabilitation facility,
9.1% were discharged under hospice care, and 3.7%
were discharged home; 16.2% of the patients expired
during the initial hospitalization. Twenty-five percent
of these were intubated, 25% of these were ICU-admits
and 20.96% of were admitted to the step-down unit.
Of the patients, 41.6% were readmitted to the hospital
within 1 year of their initial visit. Out of these, 54.5%
were discharged back to nursing homes, 3.3% to a45.3%
14.2%
10.1%
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Figure 4 Physical examination findings on presentation to the ED.
Table 4 Laboratory values on presentation to the ED
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14.6% home, and 8.1% of these patients expired during
the 1-year follow-up re-admission to the hospital.
Comparing patients before and after the publication of
the 2005 ATS/IDSA guidelines, NHAP was appropriately
treated per the guidelines 59.4% versus 41.3%, treated as
CAP 26.1% versus 18.7% of the time and treated with
a single antibiotic 46.4% versus 33.3%, respectively.
All comparisons were statistically significance with a
p-value < 0.05. Cefepime and tobramycin ± vancomycin
were utilized most often.
For mortality prediction, time until first antibiotic in uni-
variate analysis was nearly significant, p = 0.053, and the ap-
propriate versus inappropriate antibiotic did not affect
mortality. Regarding LOS, those treated with a single anti-
biotic had significantly increased LOS (p = 0.0089) and
those treated with a CAP antibiotic had a shorter LOS
(p = 0.049). Patients receiving clindamycin or piperacillin/
tazobactam had a longer LOS (p = 0.043 and 0.038),
respectively. There was poor correlation between LOS and
time until first ABX or LOS and time until appropriateTable 3 Vital signs on presentation to the ED
Mean (±SD)
Systolic blood pressure 131.86 mmHg (SD ± 30.14)
Diastolic blood pressure 66.82 mmHg (SD ± 16.12)
Heart rate 92.38 beats per minute (SD ± 22.92)
Respiratory rate 24.74 breaths per minute (SD ± 6.97)
Temperature 37.35°C (SD ± 1.08)
Oxygen saturation 94.15% (SD ± 6.085)
Initial GCS 12.82 (SD ± 2.96)ABX with a correlation coefficient of −0.048 (p = 0.42)
and −0.08 (p = 0.43), respectively.
Patients that died during initial hospitalization had a
higher respiratory rate, glucose, blood urea nitrogen (BUN)
and creatinine levels; lower GCS scores and hemoglobin
level; more dyspnea on presentation; and increased inci-
dence of mental status changes and intubations than those
discharged alive. On step-down multivariable logistic re-
gression analysis, increased heart rate, hematocrit and
BUN, decreased temperature and hemoglobin, and pres-
ence of a mental status change were found to be the stron-
gest predictors of death (Table 2). Patients who were
intubated (19.57 ± 16.8 vs. 9.31 ± 6.6, p < 0.0001) and febrile
(10.07 ± 9.6 vs. 11.58 ± 9, p < 0.012) had longer LOS. As age
increases, LOS decreases (Spearman’s correlation coeffi-
cient −0.140, p = 0.017); and as respiratory rate and
temperature increase, LOS increases (Spearman’s correl-
ation coefficient 0.165 and 0.146, p = 0.006 and 0.015,
respectively).Mean (±SD)
WBC Count 13.8 × 109/L (SD ± 12.3)
Hemoglobin Level 11.4 mg/dL (SD ± 2.0),
Hematocrit 34.9% (SD ± 6.4)
Platelet count 287 × 109/L (SD ± 136.8)
Neutrophil count 10.7 × 109/L (SD ± 6.8)
Lymphocyte count 1.6 × 109/L (SD ± 5.0)
Blood glucose level 146.39 mg/dL (SD ± 78.1)
BUN 36.07 mg/dL (SD ± 26.4)
Serum sodium concentration 138.17 mmol/L (SD ± 13.8)
Serum creatinine level 1.7 mg/dL (SD ± 1.5)
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This data set represents one of the largest studies of nurs-
ing home patients with pneumonia presenting to the ED.
We found a surprisingly low prevalence of true-positive
blood cultures (9%) and low yield and poor correlation in
sputum cultures, high incidence of antibiotic pre-
treatment at nursing homes prior to admission (27.7%),
high hospital and 1-year mortality (16.2% and 24.2%)
and low immunization rates (18.9%). There was a wide
spectrum of pathogens grown in blood culture. Only
two thirds of the patients had dyspnea as the presenting
complaint and less than half had either cough or fever
(Figure 3). On physical examination of the chest and
lungs, about one fourth had no clinical findings consist-
ent with pneumonia (Figure 4). Further, less than one
fifth of chest x-rays were interpreted as possible pneu-
monia. These findings coupled with few recorded fevers,
hypoxia and elevated WBC counts make the ED diagno-
sis of pneumonia very difficult and therefore affects the
management (Tables 3 and 4).
Since the 2005 ATS/IDSA guidelines, there has been a
decline in the number of appropriately treated NHAP
patients, as recommended by these guidelines, but also a
decrease in the number of patients who were treated as
having CAP or treated with a single antibiotic.
There was a correlation between time to first ABX and
mortality. Those patients that received only a single
ABX had a significantly increased LOS. Clindamycin, pi-
peracillin/tazobactam or CAP-directed antibiotics also
affected LOS; however, co-linearity with severity of dis-
ease may be present.
The best early ED predictors of in-hospital mortality are
decreased mental status and anemia. Elevated temperature
and signs of dehydration were also predictive of in-hospital
mortality. Hospital length of stay was related to age, ele-
vated temperature, intubation and respiratory rate.
Conclusions
In this data set of NHAP patients admitted through the
ED, we found a surprisingly low prevalence of true-positive
blood cultures and low yield and poor correlation in spu-
tum cultures, high incidence of antibiotic pre-treatment at
nursing homes prior to admission, high hospital mortality
and low immunization rates. There was a wide spectrum of
pathogens grown in blood culture. Only two thirds of the
patients had dyspnea as the presenting complaint, and less
than half had either cough or fever. On physical examin-
ation, about one fourth had no clinical findings consistent
with pneumonia. Further, less than one fifth of chest x-rays
were interpreted as possible pneumonia. In the light of
these findings, we conclude that the patients presenting
with pneumonia to the ED from nursing homes and long-
term care facilities are a high-risk group with significant
mortality and present unique diagnostic and treatmentchallenges to emergency physicians. Prospective, high-
quality randomized controlled trials investigating empiric
antibiotic therapy to determine the effect of appropriate
regimen on clinical outcomes are needed to support the
implementation of the ATS/IDSA guidelines.
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